Eric Lancelot, PhD - Publications

Affiliations: 
Guerbet Pharmaceuticals, Paris, Aulnay-sous-Bois, Île-de-France, France 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Fréchou M, Beray-Berthat V, Raynaud JS, Mériaux S, Gombert F, Lancelot E, Plotkine M, Marchand-Leroux C, Ballet S, Robert P, Louin G, Margaill I. Detection of vascular cell adhesion molecule-1 expression with USPIO-enhanced molecular MRI in a mouse model of cerebral ischemia. Contrast Media & Molecular Imaging. 8: 157-64. PMID 23281288 DOI: 10.1002/cmmi.1512  1
2012 Sigovan M, Kaye E, Lancelot E, Corot C, Provost N, Majd Z, Breisse M, Canet-Soulas E. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Investigative Radiology. 47: 546-52. PMID 22864378 DOI: 10.1097/RLI.0b013e3182631e68  1
2012 Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel JB, Corot C, Ballet S. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging. Molecular Pharmaceutics. 9: 850-61. PMID 22352457 DOI: 10.1021/mp2003863  1
2011 Hyafil F, Vucic E, Cornily JC, Sharma R, Amirbekian V, Blackwell F, Lancelot E, Corot C, Fuster V, Galis ZS, Feldman LJ, Fayad ZA. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. European Heart Journal. 32: 1561-71. PMID 21118852 DOI: 10.1093/eurheartj/ehq413  1
2010 Sigovan M, Bessaad A, Alsaid H, Lancelot E, Corot C, Neyran B, Provost N, Majd Z, Breisse M, Canet-Soulas E. Assessment of age modulated vascular inflammation in ApoE-/- mice by USPIO-enhanced magnetic resonance imaging. Investigative Radiology. 45: 702-7. PMID 20829703 DOI: 10.1097/RLI.0b013e3181f16e5a  1
2010 Bazeli R, Coutard M, Duport BD, Lancelot E, Corot C, Laissy JP, Letourneur D, Michel JB, Serfaty JM. In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms. Investigative Radiology. 45: 662-8. PMID 20733508 DOI: 10.1097/RLI.0b013e3181ee5bbf  1
2010 Klink A, Lancelot E, Ballet S, Vucic E, Fabre JE, Gonzalez W, Medina C, Corot C, Mulder WJ, Mallat Z, Fayad ZA. Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 403-10. PMID 20139362 DOI: 10.1161/ATVBAHA.109.198556  1
2010 BrÃ¥tane BT, Walvick RP, Corot C, Lancelot E, Fisher M. Characterization of gadolinium-based dynamic susceptibility contrast perfusion measurements in permanent and transient MCAO models with volumetric based validation by CASL. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 336-42. PMID 19826434 DOI: 10.1038/jcbfm.2009.218  1
2009 Idée JM, Port M, Dencausse A, Lancelot E, Corot C. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update. Radiologic Clinics of North America. 47: 855-69, vii. PMID 19744600 DOI: 10.1016/j.rcl.2009.06.006  1
2009 Burtea C, Laurent S, Lancelot E, Ballet S, Murariu O, Rousseaux O, Port M, Vander Elst L, Corot C, Muller RN. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques. Molecular Pharmaceutics. 6: 1903-19. PMID 19743879 DOI: 10.1021/mp900106m  1
2009 Sigovan M, Boussel L, Sulaiman A, Sappey-Marinier D, Alsaid H, Desbleds-Mansard C, Ibarrola D, Gamondès D, Corot C, Lancelot E, Raynaud JS, Vives V, Laclédère C, Violas X, Douek PC, et al. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology. 252: 401-9. PMID 19703881 DOI: 10.1148/radiol.2522081484  1
2009 Burtea C, Laurent S, Port M, Lancelot E, Ballet S, Rousseaux O, Toubeau G, Vander Elst L, Corot C, Muller RN. Magnetic resonance molecular imaging of vascular cell adhesion molecule-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe. Journal of Medicinal Chemistry. 52: 4725-42. PMID 19580288 DOI: 10.1021/jm9002654  1
2009 Amirbekian V, Aguinaldo JG, Amirbekian S, Hyafil F, Vucic E, Sirol M, Weinreb DB, Le Greneur S, Lancelot E, Corot C, Fisher EA, Galis ZS, Fayad ZA. Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo. Radiology. 251: 429-38. PMID 19224894 DOI: 10.1148/radiol.2511080539  1
2009 Alsaid H, De Souza G, Bourdillon MC, Chaubet F, Sulaiman A, Desbleds-Mansard C, Chaabane L, Zahir C, Lancelot E, Rousseaux O, Corot C, Douek P, Briguet A, Letourneur D, Canet-Soulas E. Biomimetic MRI contrast agent for imaging of inflammation in atherosclerotic plaque of ApoE-/- mice: a pilot study. Investigative Radiology. 44: 151-8. PMID 19169144 DOI: 10.1097/RLI.0b013e31819472ac  1
2008 Corot C, Robert P, Lancelot E, Prigent P, Ballet S, Guilbert I, Raynaud JS, Raynal I, Port M. Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 1337-46. PMID 19025883 DOI: 10.1002/mrm.21773  1
2008 Idée JM, Port M, Medina C, Lancelot E, Fayoux E, Ballet S, Corot C. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. Toxicology. 248: 77-88. PMID 18440117 DOI: 10.1016/j.tox.2008.03.012  1
2008 Müller K, Skepper JN, Tang TY, Graves MJ, Patterson AJ, Corot C, Lancelot E, Thompson PW, Brown AP, Gillard JH. Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging. Biomaterials. 29: 2656-62. PMID 18377983 DOI: 10.1016/j.biomaterials.2008.03.006  1
2008 Lancelot E, Amirbekian V, Brigger I, Raynaud JS, Ballet S, David C, Rousseaux O, Le Greneur S, Port M, Lijnen HR, Bruneval P, Michel JB, Ouimet T, Roques B, Amirbekian S, et al. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 425-32. PMID 18258820 DOI: 10.1161/ATVBAHA.107.149666  1
2007 Chaubet F, Bertholon I, Serfaty JM, Bazeli R, Alsaid H, Jandrot-Perrus M, Zahir C, Even P, Bachelet L, Touat Z, Lancelot E, Corot C, Canet-Soulas E, Letourneur D. A new macromolecular paramagnetic MR contrast agent binds to activated human platelets. Contrast Media & Molecular Imaging. 2: 178-88. PMID 17828728 DOI: 10.1002/cmmi.144  1
2007 Durand E, Raynaud JS, Bruneval P, Brigger I, Al Haj Zen A, Mandet C, Lancelot E, Lafont A. Magnetic resonance imaging of ruptured plaques in the rabbit with ultrasmall superparamagnetic particles of iron oxide. Journal of Vascular Research. 44: 119-28. PMID 17215583 DOI: 10.1159/000098484  1
2007 Müller K, Skepper JN, Posfai M, Trivedi R, Howarth S, Corot C, Lancelot E, Thompson PW, Brown AP, Gillard JH. Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials. 28: 1629-42. PMID 17178155 DOI: 10.1016/j.biomaterials.2006.12.003  1
2005 Corot C, Robert P, Lancelot E, Martinell A, Santus R. Distribution of gadomelitol in a human breast tumor model in mice. Magma (New York, N.Y.). 18: 138-43. PMID 16047191 DOI: 10.1007/s10334-005-0105-9  1
2004 Idé JM, Lancelot E, Pines E, Corot C. Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view. Investigative Radiology. 39: 155-70. PMID 15076008 DOI: 10.1097/01.rli.0000101483.60710.2c  1
2002 Lancelot E, Idée JM, Laclédère C, Santus R, Corot C. Effects of two dimeric iodinated contrast media on renal medullary blood perfusion and oxygenation in dogs. Investigative Radiology. 37: 368-75. PMID 12068157 DOI: 10.1097/00004424-200207000-00002  1
2001 Port M, Corot C, Raynal I, Idee JM, Dencausse A, Lancelot E, Meyer D, Bonnemain B, Lautrou J. Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. Investigative Radiology. 36: 445-54. PMID 11500594  1
2000 Klivenyi P, Andreassen OA, Ferrante RJ, Lancelot E, Reif D, Beal MF. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport. 11: 1265-8. PMID 10817604  1
2000 Idée JM, Lancelot E, Berthommier C, Couturier-Goulas V, Vazin V, Corot C. Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats. Fundamental & Clinical Pharmacology. 14: 11-8. PMID 10681069  1
2000 Klivenyi P, Andreassen OA, Ferrante RJ, Dedeoglu A, Mueller G, Lancelot E, Bogdanov M, Andersen JK, Jiang D, Beal MF. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 1-7. PMID 10627575  1
1998 Lancelot E, Beal MF. Glutamate toxicity in chronic neurodegenerative disease. Progress in Brain Research. 116: 331-47. PMID 9932386  1
1998 Lancelot E, Revaud ML, Boulu RG, Plotkine M, Callebert J. A microdialysis study investigating the mechanisms of hydroxyl radical formation in rat striatum exposed to glutamate. Brain Research. 809: 294-6. PMID 9853122 DOI: 10.1016/S0006-8993(98)00942-1  1
1998 Lancelot E, Lecanu L, Revaud ML, Boulu RG, Plotkine M, Callebert J. Glutamate induces hydroxyl radical formation in vivo via activation of nitric oxide synthase in Sprague-Dawley rats. Neuroscience Letters. 242: 131-4. PMID 9530923 DOI: 10.1016/S0304-3940(98)00095-0  1
1997 Lancelot E, Revaud ML, Boulu RG, Plotkine M, Callebert J. alpha-Phenyl-N-tert-butylnitrone attenuates excitotoxicity in rat striatum by preventing hydroxyl radical accumulation. Free Radical Biology & Medicine. 23: 1031-4. PMID 9358246 DOI: 10.1016/S0891-5849(97)00128-7  1
1995 Lancelot E, Callebert J, Lerouet D, Revaud ML, Boulu RG, Plotkine M. Role of the L-arginine-nitric oxide pathway in the basal hydroxyl radical production in the striatum of awake rats as measured by brain microdialysis. Neuroscience Letters. 202: 21-4. PMID 8787821 DOI: 10.1016/0304-3940(95)12211-7  1
1995 Lancelot E, Callebert J, Revaud ML, Boulu RG, Plotkine M. Detection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damage. Neuroscience Letters. 197: 85-8. PMID 8552286 DOI: 10.1016/0304-3940(95)11901-8  1
1995 Lancelot E, Callebert J, Plotkine M, Boulu RG. Striatal dopamine participates in glutamate-induced hydroxyl radical generation. Neuroreport. 6: 1033-6. PMID 7632889  1
1994 Lancelot E, Callebert J, Buisson A, Plotkine M, Boulu RG. The role of dopamine on the vulnerability of the ischemic striatum | ROLE DE LA DOPAMINE DANS LA VULNERABILITE DU STRIATUM A L'ISCHEMIE Circulation Et Metabolisme Du Cerveau. 11: 299-302.  1
Show low-probability matches.